The $40 billion investment will be spread across various R&D and manufacturing areas over the next five years.

Bristol Myers Squibb plans to inject $40 billion into U.S. operations over the next five years, mixing business ambition with ...

US pharma major Bristol Myers Squibb is planning a massive $40 billion investment in the country over the next five years.

Bristol Myers Squibb has appointment Cari Gallman as executive vice president, general counsel and chief policy officer, ...

Gallman takes on the role of EVP, General Counsel and Chief Policy Officer, following Sandra Leung’s retirement after 33 ...

BMS pledges $40B over five years to boost U.S. R&D, tech innovation, and pharmaceutical manufacturing under CEO Christopher ...

Bristol Myers Squibb helmsman Chris Boerner joined a growing list of life sciences leaders announcing major U.S. investments ...

In light of President Donald Trump’s impending pharma tariffs, several big companies have made massive manufacturing ...

Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer ...

Bristol Myers Squibb (BMS) plans to invest $40bn in the US over the next five years to bolster its research and manufacturing ...

Bristol Myers Squibb plans to invest a jaw-dropping $40 billion in the U.S. over five years to reinforce its research, tech, ...

Bristol Myers Squibb said on Monday it will invest $40 billion in the U.S. over the next five years, as it seeks to expand ...